Stay updated on I-SPY Trial: Personalized Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the I-SPY Trial: Personalized Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the I-SPY Trial: Personalized Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, representing a minor platform or formatting update rather than changes to the study details or results.
    Difference
    0.0%
    Check dated 2026-05-15T05:59:15.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Ivonescimab has been added as a novel investigational agent in Blocks A and B, and the arm is closed for accrual with enrollment completed.
    Difference
    0.5%
    Check dated 2026-05-08T09:31:02.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page’s software/display revision has been updated from **v3.5.2** to **v3.5.3**, reflecting a minor site version change rather than an update to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-24T06:00:41.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:45:23.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added a new publication citation to the Publications section: Teng X, Ma J, Zhang J, Zhao M, Meng X, Yin Y, Xiao H, Lai Q, Zhang X, Jiang Y, Cai J. Longitudinal DCE MRI Vascular Textures: Radiologic and Biologic Insights for pCR Prediction in HER2-Negative Breast Cancer. Radiol Artif Intell. 2026 Mar 25:e250734. Online ahead of print.
    Difference
    0.0%
    Check dated 2026-04-02T15:29:46.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added Angiosarcoma as a listed condition, and updated contact details to include Heather Prisant (Clinical Research Coordinator) with emails. Maria Pitsiouni, PhD has been removed from the contact list, and the page revision indicates v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T05:12:56.000Z thumbnail image

Stay in the know with updates to I-SPY Trial: Personalized Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the I-SPY Trial: Personalized Breast Cancer Clinical Trial page.